NCT00079274
Clinical Trial Information
Trial Number: NCT00079274 (ClinicalTrials.gov)
Disease Type:
- Gastrointestinal Neoplasm - Colorectal Cancer
Trial Title:
A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) With or Without Cetuximab (C225) After Curative Resection for Patients With Stage III Colon Cancer
Study ID:
N0147
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00079274-D3 | The NCT00079274-D3-Dataset.csv dataset is one of 3 datasets associated with PubMed ID 22474202. This dataset contains information on grade 3 or higher reported toxicity. |
| NCT00079274-D2 | The NCT00079274-D2-Dataset.csv dataset is one of 3 datasets associated with PubMed ID 22474202. This dataset contains information on overall survival, disease free survival and time to recurrence analyses. |
| NCT00079274-D1 | The NCT00079274-D1-Dataset.csv dataset is one of 3 datasets associated with PubMed ID 22474202. This dataset contains information on baseline characteristics, eligibility, and follow-up status. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®